SCHEMBL522381

SCHEMBL522381

CCCCN(OCCCO)OCCCO

nearest known ligand 0.43

Predicted protein targets (top 15)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 3/20 0.43
SMN1; SMN2 Q16637 1/20 0.42
LMNA P02545 2/20 0.40
TSHR P16473 2/20 0.40
MEN1 O00255 2/20 0.40
KMT2A Q03164 2/20 0.40
HSD17B10 Q99714 1/20 0.40
THRB P10828 1/20 0.35
HTT P42858 1/20 0.35
MAPT P10636 1/20 0.35
ACHE P22303 7/20 0.32
ALDH2 P05091 1/20 0.31
CA12 O43570 1/20 0.31
CA1 P00915 1/20 0.31
CA9 Q16790 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3218812 0.93 SMN1; SMN2 (0.46) ALDH1A1SMN1; SMN2LMNATSHRMEN1
SCHEMBL974561 0.93 SMN1; SMN2 (0.46) ALDH1A1SMN1; SMN2LMNATSHRMEN1
SCHEMBL16390224 0.91 TSHR (0.48) ALDH1A1SMN1; SMN2LMNATSHRMEN1
SCHEMBL16390097 0.91 TSHR (0.48) ALDH1A1SMN1; SMN2LMNATSHRMEN1
SCHEMBL2045498 0.91 TSHR (0.48) ALDH1A1SMN1; SMN2LMNATSHRMEN1
SCHEMBL2045371 0.91 TSHR (0.48) ALDH1A1SMN1; SMN2LMNATSHRMEN1
SCHEMBL1548800 0.91 LMNA (0.48) ALDH1A1SMN1; SMN2LMNATSHRMEN1
SCHEMBL16390292 0.91 TSHR (0.48) ALDH1A1SMN1; SMN2LMNATSHRMEN1
SCHEMBL487208 0.91 TSHR (0.48) ALDH1A1SMN1; SMN2LMNATSHRMEN1
SCHEMBL381662 0.91 TSHR (0.48) ALDH1A1SMN1; SMN2LMNATSHRMEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 144 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2097476-B1 AMINE NEUTRALIZING AGENTS FOR LOW VOLATILE COMPOUND ORGANIC PAINTS TAMINCO (BE) 2020-04-29 EP claimed
US-10336668-B2 Method for producing cis- and trans-enriched MDACH BASF SE (DE) 2019-07-02 US claimed
EP-3224235-B1 PROCESS FOR THE PREPARATION OF CIS- AND TRANS-ENRICHED MDACH BASF SE (DE) 2018-11-14 EP claimed
US-20170260115-A1 METHOD FOR PRODUCING CIS- AND TRANS-ENRICHED MDACH BASF SE (DE) 2017-09-14 US claimed
CN-101578331-B Amine neutralizing agents for low volatile compound organic paints TAMINCO 2012-12-12 CN claimed
US-20100041801-A1 AMINE NEUTRALIZING AGENTS FOR LOW VOLATILE COMPOUND ORGANIC PAINTS TAMINCO NV (BE) 2010-02-18 US claimed
EP-2097476-A1 AMINE NEUTRALIZING AGENTS FOR LOW VOLATILE COMPOUND ORGANIC PAINTS Taminco (BE) 2009-09-09 EP claimed
WO-2008081036-A1 AMINE NEUTRALIZING AGENTS FOR LOW VOLATILE COMPOUND ORGANIC PAINTS TAMINCO (BE) 2008-07-10 WO claimed
US-20080066644-A1 Alkylmines, alkanolamine compounds, surfactants, a coloring agent and a solvent; combination results in decreased kogation SAMSUNG ELECTRONICS CO., LTD. (KR) 2008-03-20 US claimed
EP-1900785-A1 Ink Composition for Inkjet Recording Samsung Electronics Co., Ltd. (KR) 2008-03-19 EP claimed
US-5403689-A Amide functionality XEROX CORPORATION (US) 1995-04-04 US claimed
CN-118355096-A Water-soluble metal processing oil 出光兴产株式会社 2024-07-16 CN disclosed
WO-2024095923-A1 CLEANING LIQUID AND METHOD FOR CLEANING SUBSTRATE 東京応化工業株式会社 2024-05-10 WO disclosed
CN-109789064-B Methods, compositions and uses related thereto 因诺斯佩克有限公司 2023-11-21 CN disclosed
CN-109789065-B Cosmetic composition for combating colour loss of dyed material 因诺斯佩克有限公司 2023-11-21 CN disclosed
EP-1088868-A2 Composition for film formation, method of film formation, and insulating film JSR Corporation (JP) 2001-04-04 EP disclosed
US-5459197-A Polyurethanes for protective coatings on substrates BAYER AKTIENGESELLSCHAFT (DE) 1995-10-17 US disclosed
US-5403689-A Amide functionality XEROX CORPORATION (US) 1995-04-04 US disclosed
EP-0483406-A1 A magnetic recording medium DAINICHISEIKA COLOR & CHEMICALS MFG. CO. LTD. (JP) 1992-05-06 EP disclosed
EP-0083232-A1 Aqueous compositions comprising blocked isocyanate crosslinking agent FORD MOTOR COMPANY LIMITED (GB) 1983-07-06 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20170260115-A1 METHOD FOR PRODUCING CIS- AND TRANS-ENRICHED MDACH ADH1C, MDH1, DNMT1 ALDH1A1 104/4885SMN1; SMN2 1498/4885LMNA 1999/4885
US-10336668-B2 Method for producing cis- and trans-enriched MDACH ADH1C, MDH1, DNMT1 ALDH1A1 104/4885SMN1; SMN2 1498/4885LMNA 1999/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.